Quidel Corp

$103.37 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Quidel Corp

Quidel Corporation is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The Company is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. These diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions, and specialized diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and other medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases.

Stock Analysis

last close $103.37
1-mo return -6.8%
3-mo return 16.9%
avg daily vol. 604.23T
52-week high 180.06
52-week low 88.05
market cap. $4.2B
forward pe 14.8
annual div. -
roe 51.5%
ltg forecast -
dividend yield -
annual rev. $2.3B
inst own. 91.8%

Subscribe now for daily local and international financial news